Next 10 |
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced that it will hold a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern Ti...
HeartBeam, Inc . (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, will hold a conference call on Thursday May 9, 2024 at 4:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024, and wil...
2024-04-09 09:35:26 ET More on HeartBeam HeartBeam, Inc. 2023 Q4 - Results - Earnings Call Presentation HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript HeartBeam reports Q4 results HeartBeam gains on receipt of two US patents for its core cardiac moni...
New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company’s Deep Learning Technology Data Shows HeartBeam AI Combined with VCG Greatly Improves Detection of Atrial Flutter over Single-Lead ECGs Found in L...
2024-03-22 07:53:45 ET More on pre market gainers & stock GRIID Infrastructure plans to add 60 MW bitcoin mining facility in Tennessee, stock soars Financial information for GRIID INFRASTRUCTURE INC. Financial information for Nutriband Financial informati...
HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced its financial numbers and operational highlights for the fourth quarter and full year ended Dec. 31, 2023. According to the report, key achievemen...
2024-03-20 19:35:23 ET Start Time: 16:30 End Time: 17:11 HeartBeam, Inc. (BEAT) Q4 2023 Earnings Conference Call March 20, 2024, 16:30 PM ET Company Participants Branislav Vajdic - CEO and Founder Rob Eno - President Deborah Castillo - VP of Regulatory Af...
2024-03-20 16:16:01 ET More on HeartBeam HeartBeam gains on receipt of two US patents for its core cardiac monitoring technology Seeking Alpha’s Quant Rating on HeartBeam Historical earnings data for HeartBeam Financial information for HeartBeam ...
First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing Clinical and Regulatory Progress for the AIMIGo 3D VECG System Recently Received 2 New Patents for our Proprietary Technologies Management to Host W...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...
News, Short Squeeze, Breakout and More Instantly...
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced that it will hold a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern Ti...
HeartBeam, Inc . (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, will hold a conference call on Thursday May 9, 2024 at 4:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024, and wil...
New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company’s Deep Learning Technology Data Shows HeartBeam AI Combined with VCG Greatly Improves Detection of Atrial Flutter over Single-Lead ECGs Found in L...